Blueprint Medicines Corporation (BPMC)

Blueprint Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6,910	5,607	2,621	6,302	6,250	3,942
Market Cap Growth	115.24%	113.92%	-58.41%	0.83%	58.57%	66.36%
Enterprise Value	6,582	5,219	1,913	5,931	5,463	3,549
PE Ratio	-	-11.06	-4.70	-9.78	19.91	-11.34
PS Ratio	24.49	22.49	12.85	35.00	7.87	59.26
PB Ratio	22.24	42.93	5.09	6.49	4.25	8.49
P/FCF Ratio	-13.51	-12.38	-5.13	-20.89	16.28	-13.50
P/OCF Ratio	-13.98	-12.84	-5.22	-21.10	16.15	-14.18
EV/Sales Ratio	23.32	20.93	9.38	32.94	6.88	53.36
EV/EBITDA Ratio	-22.21	-11.19	-3.71	-9.40	17.03	-10.11
EV/EBIT Ratio	-20.39	-10.71	-3.57	-9.22	17.72	-9.82
EV/FCF Ratio	-12.74	-11.52	-3.74	-19.66	14.23	-12.15
Debt / Equity Ratio	1.06	2.55	0.47	0.11	0.06	0.21
Debt / EBITDA Ratio	-1.34	-0.71	-0.47	-0.18	0.28	-0.27
Debt / FCF Ratio	-0.77	-0.73	-0.47	-0.37	0.23	-0.33
Quick Ratio	3.48	3.55	5.39	3.47	6.90	4.81
Current Ratio	3.76	3.76	5.71	3.70	7.09	4.85
Asset Turnover	0.26	0.22	0.16	0.12	0.63	0.10
Interest Coverage	-14.25	-25.93	-31.94	-	-	-
Return on Equity (ROE)	-120.70%	-191.60%	-80.10%	-52.10%	31.00%	-72.50%
Return on Assets (ROA)	-26.80%	-45.30%	-43.40%	-43.50%	25.10%	-49.70%
Return on Capital (ROIC)	-68.80%	-105.00%	-70.99%	-59.32%	19.73%	-64.49%
Earnings Yield	-4.17%	-9.04%	-21.27%	-10.22%	5.02%	-8.82%
FCF Yield	-6.22%	-8.08%	-19.50%	-4.79%	6.14%	-7.41%
Buyback Yield / Dilution	-6.11%	-1.54%	-1.92%	-4.18%	-17.44%	-9.03%
Total Shareholder Return	-6.11%	-1.54%	-1.92%	-4.18%	-17.44%	-9.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).